Table 3.

Multivariable analysis of post-progression survival of patients with PTEN-mutant recurrent glioblastoma (rGBM) IDH-WT (N = 70)

Variables	HR (CI 95%)	p-value
Age (years)	1.00 (0.98–1.03)	0.778
Male	0.77 (0.42–1.42)	0.404
Preoperative KPS ≥ 80	0.59 (0.30–1.17)	0.130
Non-GTR	1.72 (0.85–3.48)	0.134
Salvage TMZ	0.84 (0.43–1.65)	0.610
Salvage bevacizumab	0.91 (0.48–1.73)	0.775
Salvage TTFields	0.29 (0.12–0.66)	0.003

Significant p-values are bolded

Multivariate analysis was performed using a Cox regression model

TTFields tumor treating fields, KPS Karnofsky Performance Status, GTR Gr oss-total resection TMZ temozolomide, HR hazard ratio, CI confidence interval, WT wildtype